July 19, 2022 — Employing artificial intelligence to help improve outcomes for people with cardiovascular disease is the ...
July 18, 2022 — 3DR Labs, an Accumen company, today announced the launch of its Cardiac Center of Excellence and Imaging ...
July 18, 2022 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 18, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products that ...
During the Society of Cardiovascular Computed Tomography 17th Annual Scientific Meeting (SCCT2022), three awards were ...
July 15, 2022 — The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 15, 2022 — Imagine, if scientists had a map of the heart, so granular in its accuracy that it even profiled details ...
July 15, 2022 — The American Heart Association, the leading voluntary organization devoted to longer, healthier lives ...
July 14, 2022 — University of Toronto Engineering researchers have grown a small-scale model of a human left heart ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 14, 2022 — More than one in four pregnancy-related deaths (26.5%) in the U.S. are tied to poor heart health ...
July 14, 2022 — Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a ...
July 14, 2022 – AvoMD, a next-generation application-based clinical decision support platform, is working with the ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 13, 2022 — Black children who underwent heart transplant surgery for the first time were more than three times as ...
July 13, 2022 — Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening ...
July 13, 2022 — Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure, today ...